SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-087867
Filing Date
2020-07-29
Accepted
2020-07-29 17:25:50
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20200630x10q.htm   iXBRL 10-Q 1568176
2 EX-31.1 inva-20200630xex31d1.htm EX-31.1 8619
3 EX-31.2 inva-20200630xex31d2.htm EX-31.2 8607
4 EX-32 inva-20200630xex32.htm EX-32 10247
  Complete submission text file 0001104659-20-087867.txt   6037923

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA inva-20200630.xsd EX-101.SCH 36129
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inva-20200630_cal.xml EX-101.CAL 62493
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20200630_def.xml EX-101.DEF 143010
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20200630_lab.xml EX-101.LAB 351879
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20200630_pre.xml EX-101.PRE 271583
10 EXTRACTED XBRL INSTANCE DOCUMENT inva-20200630x10q_htm.xml XML 1228632
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 201058061
SIC: 2834 Pharmaceutical Preparations